Clinical trial protocol of the ASTER trial: a double-blind, randomized, placebo-controlled phase III trial evaluating the use of acetylsalicylic acid (ASA) for enhanced early detection of colorectal neoplasms

ᅟ: Immunochemical fecal occult blood tests (iFOBTs) are increasingly used for colorectal cancer (CRC) screening. In our preceding observational study, sensitivity for detecting advanced colorectal neoplasms by iFOBT was 70.8% among users of low-dose acetylsalicylic acid compared with 35.9% among non...

Descripción completa

Detalles Bibliográficos
Autores principales: Tikk, Kaja, Czock, David, Haefeli, Walter E., Kopp-Schneider, Annette, Brenner, Hermann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154882/
https://www.ncbi.nlm.nih.gov/pubmed/30249195
http://dx.doi.org/10.1186/s12885-018-4826-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154882/
https://www.ncbi.nlm.nih.gov/pubmed/30249195
http://dx.doi.org/10.1186/s12885-018-4826-3

Ejemplares similares